Studies based on the interaction between serum proteins and leptin show that human CRP directly inhibits the binding of leptin to the receptor in vitro and blocks the signaling pathway of leptin, which suggests that CRP can promote obesity and metabolic complications [77]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.